Opioid- and Stimulant-related Harms in Canada: Key findings
The most recent available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to June 2025 in Canada, where available.
- Last updated: 2025-12-11
- Download data in ZIP format
On this page
Context
Canada has seen substantially elevated numbers of toxic drug poisonings since national surveillance began in 2016 by the Public Health Agency of Canada. This public health crisis is having a tragic impact on people who use substances, their families, and communities across the country, and is shaped by a wide range of factors. Since 2020, several jurisdictions have reported higher rates of toxic drug poisoning with fluctuations in recent quarters.
Presented here are the most recent available data on opioid- and stimulant-related poisonings in Canada, where available. For more details on additional studies and other products related to the toxic drug crisis, refer to the Data, surveillance and research page.
Key updates
Reported in the last 12 months () in Canada
{Deaths}
Apparent opioid toxicity deathsFootnote 1Footnote 2Footnote 3Footnote 4
(%% higher than the previous 12 months)
{Deaths per day}
Deaths per day on average
{Hospitalizations}
Opioid-related poisoning hospitalizationsFootnote 8Footnote 9
(%% higher than the previous 12 months)
{Hospitalizations per day}
Hospitalizations per day on average
{ED visits}
Opioid-related poisoning Emergency Department (ED) visitsFootnote 10Footnote 11
(%% higher than the previous 12 months)
{ED visits per day}
ED visits per day on average
{Emergency Medical Services (EMS) responses}
Emergency Medical Services (EMS) responses to suspected opioid-related overdosesFootnote 13
(%% higher than the previous 12 months)
{EMS responses per day}
EMS responses per day on average
Report summary
Deaths
- There was a total of 53,308 apparent opioid toxicity deaths reported between January 2016 and June 2025Footnote 3.
- A total of 2,787 apparent opioid toxicity deaths have been reported so far in 2025 (Jan to Jun), of which 97% were accidentalFootnote 1Footnote 2Footnote 3.
- So far in 2025 (Jan to Jun), most (78%) apparent opioid toxicity deaths in Canada occurred in British Columbia, Alberta, and OntarioFootnote 2.
- Most apparent opioid toxicity deaths occurred among males (72%) and among individuals aged 30 to 39 years (26%) so far in 2025 (Jan to Jun)Footnote 1Footnote 2.
- Of all apparent opioid toxicity deaths so far in 2025 (Jan to Jun), 57% involved fentanyl and 57% involved fentanyl analoguesFootnote 2.
- Of all apparent opioid toxicity deaths so far in 2025 (Jan to Jun), 83% involved opioids that were non-pharmaceuticalFootnote 5Footnote 6.
- Of all apparent opioid toxicity deaths so far in 2025 (Jan to Jun), 68% also involved a stimulantFootnote 7.
Hospitalizations
- There was a total of 50,558 opioid-related poisoning hospitalizations reported between January 2016 to June 2025Footnote 8.
- A total of 2,331 opioid-related poisoning hospitalizations have been reported so far in 2025 (Jan to Jun), of which 69% were accidentalFootnote 9.
- Most opioid-related poisoning hospitalizations occurred among males (58%) and among individuals aged 60 years or more (27%) so far in 2025 (Jan to Jun).
- Of all opioid-related poisoning hospitalizations so far in 2025 (Jan to Jun), 24% involved fentanyl or its analogues. This percentage has increased by 50% since 2018 when national surveillance began but appears to have stabilized in recent years.
- Of all opioid-related poisoning hospitalizations so far in 2025 (Jan to Jun), 14% also involved a stimulant.
- Of all accidental stimulant-related poisoning hospitalizations so far in 2025 (Jan to Jun), 36% also involved an opioid.
Emergency department visits
- There were 208,615 reported opioid-related poisoning emergency department visits reported between January 2016 to June 2025Footnote 10.
- A total of 10,408 opioid-related poisoning emergency department visits have been reported so far in 2025 (Jan to Jun), of which 83% were accidentalFootnote 10Footnote 11Footnote 12.
- Most opioid-related poisoning emergency department visits occurred among males (65%) and among individuals aged 30 to 39 years (32%) so far in 2025 (Jan to Jun)Footnote 10.
- Of all opioid-related poisoning emergency department visits so far in 2025 (Jan to Jun), 36% involved fentanyl or its analoguesFootnote 10. This percentage increased by 80% since 2018 when national surveillance began but appears to have stabilized in recent years.
- Of all opioid-related poisoning emergency department visits so far in 2025 (Jan to Jun), 8% also involved a stimulantFootnote 10.
- Of all stimulant-related poisoning emergency department visits so far in 2025 (Jan to Jun), 29% also involved an opioidFootnote 10.
Emergency medical services
- There was a total of 261,629 EMS responses to suspected opioid-related overdoses reported between January 2017 and June 2025Footnote 14.
- A total of 16,838 EMS responses to suspected opioid-related overdoses have been reported so far in 2025 (Jan to Jun).
- Most EMS responses to suspected opioid-related overdoses occurred among males (70%) and among individuals aged 30 to 39 years (34%) so far in 2025 (Jan to Jun) Footnote 13.
Footnotes
- Footnote 1
-
Due to the time required to complete death investigations, data on apparent opioid and stimulant toxicity deaths for the four most recent quarters are considered preliminary and subject to change. Numbers and trends should be interpreted with caution.
- Footnote 2
-
Based on data available from 12 provinces and territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and Northwest Territories.
- Footnote 3
-
The national overall count includes deaths from British Columbia related to all unregulated drugs (2024 onwards) and Quebec related to drug or opioid-related intoxication (2024 onwards).
- Footnote 4
-
Based on data available from nine provinces and territories, including British Columbia, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Newfoundland and Labrador, Yukon, and Northwest Territories.
- Footnote 5
-
Based on data available from nine provinces or territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Newfoundland and Labrador, and Northwest Territories..
- Footnote 6
-
Opioids with a pharmaceutical origin refer to opioids that were manufactured by a pharmaceutical company and approved for medical purposes in humans. Pharmaceutical origin does not indicate how the opioids were obtained (e.g., through personal prescription or by other means).
- Footnote 7
-
Based on data available from 11 provinces and territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and Northwest Territories.
- Footnote 8
-
Data on hospitalizations from Quebec are not included in the dataset used for analysis. As a result, Quebec is excluded.
- Footnote 9
-
Data from the Discharge Abstract Database on opioid and stimulant-related poisoning hospitalizations after March 31, 2025 are preliminary and subject to change. Numbers and trends should be interpreted with caution.
- Footnote 10
-
Based on data available from seven provinces and territories, including British Columbia, Alberta, Saskatchewan, Ontario, Nova Scotia, Prince Edward Island, and Yukon.
- Footnote 11
-
Data from the National Ambulatory Care Reporting System (NACRS) on opioid and stimulant-related poisoning ED visits after March 31, 2025 are preliminary and subject to change. Numbers and trends should be interpreted with caution.
- Footnote 12
-
Based on data available from six provinces and territories, including Alberta, Saskatchewan, Ontario, Nova Scotia, Prince Edward Island, and Yukon.
- Footnote 13
-
Based on data available from nine provinces and territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Yukon, and the Northwest Territories.
- Footnote 14
-
Based on data available from 10 provinces and territories, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Newfoundland and Labrador, Yukon, and the Northwest Territories.
This update is based on data submitted to or extracted by the Public Health Agency of Canada on or before . New or revised data reported after this date will be reflected in future updates. Differences may exist in case identification and reporting, type of data reported and time period of available data. Comparisons over time and between provinces and territories should be interpreted with caution.
Acknowledgments
We recognize that the data in this report may represent stories of pain, grief, and trauma. This report cannot adequately reflect the burden borne by Canadians. We acknowledge all those impacted by substance use, and those who work to save lives and reduce substance-related harms on individuals and communities.
This update would not be possible without the collaboration and dedication of provincial and territorial (PT) offices of Chief Coroners and Chief Medical Examiners as well as PT public health and health partners and Emergency Medical Services data providers. We would also like to acknowledge the Canadian Institute for Health Information (CIHI) for collecting and providing the data used for reporting opioid- and stimulant-related poisoning hospitalizations and emergency department visits.
Suggested Citation
Substance-related Overdose and Mortality Surveillance Task Group on behalf of the Council of Chief Medical Officers of Health. Opioid- and Stimulant-related Harms in Canada. Ottawa: Public Health Agency of Canada; December 2025.
Learn more about opioids and stimulants in Canada
You might also be interested in
Nitazenes in apparent opioid toxicity deaths in Canada
Data from the Canadian Coroner and Medical Examiner Database (CCMED) on apparent opioid toxicity deaths involving nitazenes in Canada, 2020 to 2024.
Decline in opioid-related deaths in Canada
Potential factors to explain the decline in opioid-related deaths in 2024 compared to 2023.
- Date modified: